封面
市场调查报告书
商品编码
1534167

全球透明质酸原料市场规模研究,按应用、按来源、按等级和区域预测 2022-2032

Global Hyaluronic Acid Raw Material Market Size study, by Application, by Source, by Grade and Regional Forecasts 2022-2032

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球透明质酸原料市场规模估计为66.1亿美元,预计2024年至2032年将以6.5%的年复合成长率(CAGR)增长。 ,特别是在关节炎和整容手术治疗方面。在越来越多的批准治疗产品的推动下,这些材料在骨关节炎治疗中的使用不断增加,促进了市场的成长。关节炎病例的增加增强了透明质酸在相关治疗中的接受度,进一步加速了市场扩张。

此外,市场对整容手术治疗中的透明质酸原料的需求激增。糖尿病患者的慢性伤口和整形外科手术需求的不断增长对透明质酸製剂产生了巨大的需求。玻尿酸独特的保湿和黏弹性特性正在推动其在抗衰老治疗、脸部线条矫正和脸颊增大过程中的应用。 FDA 批准使用透明质酸进行真皮填充剂来矫正细纹和皱纹,这也有助于这些材料的销量增加,因为它们的过敏反应风险极低。然而,由于透明质酸原料成本较高,市场面临挑战,这限制了资金紧张的终端用户的取得。此外,搔痒和血管闭塞等副作用也限制了它们的需求。

从地区来看,北美在 2023 年占据市场主导地位,收入份额最大,达 40.9%。这一重要份额归功于先进的技术、先进的医疗基础设施以及患者对美容和抗衰老手术意识的提高。该地区对微创整容手术的需求预计将推动进一步扩张。同时,亚太地区预计在预测期内将以 9.0% 的复合年增长率最快增长。该地区强大的护肤和美容文化,加上人们对日常护肤意识的不断提高,正在推动对以其保湿和抗衰老特性而闻名的透明质酸的需求。

目录

第一章:全球透明质酸原料市场执行摘要

  • 全球玻尿酸原料市场规模及预测(2022-2032)
  • 区域概要
  • 分部摘要
    • 按申请
    • 按来源
    • 按年级
  • 主要趋势
  • 经济衰退的影响
  • 分析师推荐与结论

第 2 章:全球透明质酸原料市场定义与研究假设

  • 研究目的
  • 市场定义
  • 研究假设
    • 包容与排除
    • 限制
    • 供给侧分析
      • 可用性
      • 基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性(消费者的角度)
    • 需求面分析
      • 监理框架
      • 技术进步
      • 环境考虑
      • 消费者意识和接受度
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第三章:全球玻尿酸原料市场动态

  • 市场驱动因素
    • 关节炎治疗的消费不断增长
    • 越来越多地在整容手术中使用
  • 市场挑战
    • 高价
    • 副作用
  • 市场机会
    • 加大透明质酸研发力度
    • 不断增长的医疗保健支出

第四章:全球透明质酸原料市场产业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争竞争
    • 波特五力模型的未来方法
    • 波特的五力影响分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会的
    • 技术性
    • 环境的
    • 合法的
  • 顶级投资机会
  • 最佳制胜策略
  • 颠覆性趋势
  • 产业专家视角
  • 分析师推荐与结论

第 5 章:全球透明质酸原料市场规模及预测:依应用分类 - 2022-2032

  • 细分仪表板
  • 全球透明质酸原料市场:2022年及2032年应用收入趋势分析
    • 眼科
    • 骨科
    • 皮肤科
    • 药物输送
    • 医疗器材涂层
    • 手术沾黏的预防
    • 生物材料和植入物
    • 细胞和组织保存

第 6 章:全球玻尿酸原料市场规模及预测:依来源分类 - 2022-2032

  • 细分仪表板
  • 全球透明质酸原料市场:2022年及2032年来源收入趋势分析
    • 非动物
    • 动物

第 7 章:全球玻尿酸原料市场规模及预测:依等级 - 2022-2032

  • 细分仪表板
  • 全球透明质酸原料市场:2022年及2032年等级收入趋势分析
    • 製药
    • 化妆品
    • 骨科

第 8 章:全球透明质酸原料市场规模及预测:按地区 - 2022-2032

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区

第 9 章:竞争情报

  • 重点企业SWOT分析
  • 顶级市场策略
  • 公司简介
    • AbbVie Inc.
      • 关键讯息
      • 概述
      • 财务(视数据可用性而定)
      • 产品概要
      • 市场策略
    • Salix Pharmaceuticals
    • Lifecore Biomedical, Inc.
    • Sanofi
    • Anika Therapeutics, Inc.
    • Zimmer Biomet
    • Smith+Nephew
    • LG Chem
    • Maruha Nichiro Corporation
    • Ferring BV

第 10 章:研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场预测
    • 验证
    • 出版
  • 研究属性
简介目录

The global hyaluronic acid raw material market size was estimated at USD 6.61 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2032. Hyaluronic acid raw materials are gaining significant traction across various applications, particularly in arthritis and cosmetic surgery treatments. The growing use of these materials in the treatment of osteoarthritis is contributing to market growth, driven by an increasing number of approved therapeutic products. The rise in arthritis cases is bolstering the acceptance of hyaluronic acid in related treatments, further accelerating market expansion.

Additionally, the market is witnessing a surge in demand for hyaluronic acid raw materials in cosmetic surgery treatments. Chronic wounds among diabetic patients and the rising demand for plastic surgery procedures are generating significant requirements for agents based on hyaluronic acid. The unique moisturizing and viscoelastic properties of hyaluronic acid are driving its use in anti-aging treatments, facial line corrections, and cheek augmentation processes. FDA approval for dermal fillers using hyaluronic acid for fine line and wrinkle correction is also contributing to the increased sales of these materials, driven by their minimal risk of allergic reactions. However, the market faces challenges due to the high cost of hyaluronic acid raw materials, which limits their accessibility for end users with monetary constraints. Additionally, side effects such as itching and vascular occlusion are restricting their demand.

Regionally, North America dominated the market in 2023, holding the largest revenue share of 40.9%. This significant share is attributed to advanced technologies, a sophisticated healthcare infrastructure, and increasing patient awareness of aesthetic and anti-aging procedures. The region's demand for minimally invasive cosmetic procedures is expected to drive further expansion. Meanwhile, the Asia Pacific region is anticipated to grow at the fastest CAGR of 9.0% during the forecast period. The region's strong skincare and beauty culture, coupled with increasing awareness of skincare routines, is driving the demand for hyaluronic acid, known for its moisturizing and anti-aging properties.

Major market players included in this report are:

  • AbbVie Inc.
  • Salix Pharmaceuticals
  • Lifecore Biomedical, Inc.
  • Sanofi
  • Anika Therapeutics, Inc.
  • Zimmer Biomet
  • Smith+Nephew
  • LG Chem
  • Maruha Nichiro Corporation
  • Ferring B.V.

The detailed segments and sub-segment of the market are explained below:

By Application:

  • Ophthalmology
  • Orthopedics
  • Dermatology
  • Drug Delivery
  • Medical Device Coating
  • Surgical Adhesion Prevention
  • Biomaterials and Implants
  • Cell and Tissue Preservation

By Source:

  • Non-Animal
  • Animal

By Grade:

  • Pharmaceutical
  • Cosmetic
  • Orthopedic

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Hyaluronic Acid Raw Material Market Executive Summary

  • 1.1. Global Hyaluronic Acid Raw Material Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Application
    • 1.3.2. By Source
    • 1.3.3. By Grade
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Hyaluronic Acid Raw Material Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Hyaluronic Acid Raw Material Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Growing Consumption in Arthritis Treatments
    • 3.1.2. Increasing Use in Cosmetic Surgery
  • 3.2. Market Challenges
    • 3.2.1. High Prices
    • 3.2.2. Side Effects
  • 3.3. Market Opportunities
    • 3.3.1. Increasing R&D for Hyaluronic Acid
    • 3.3.2. Growing Healthcare Spending

Chapter 4. Global Hyaluronic Acid Raw Material Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Hyaluronic Acid Raw Material Market Size & Forecasts by Application 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Hyaluronic Acid Raw Material Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Ophthalmology
    • 5.2.2. Orthopedics
    • 5.2.3. Dermatology
    • 5.2.4. Drug Delivery
    • 5.2.5. Medical Device Coating
    • 5.2.6. Surgical Adhesion Prevention
    • 5.2.7. Biomaterials and Implants
    • 5.2.8. Cell and Tissue Preservation

Chapter 6. Global Hyaluronic Acid Raw Material Market Size & Forecasts by Source 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Hyaluronic Acid Raw Material Market: Source Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Non-Animal
    • 6.2.2. Animal

Chapter 7. Global Hyaluronic Acid Raw Material Market Size & Forecasts by Grade 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Hyaluronic Acid Raw Material Market: Grade Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Pharmaceutical
    • 7.2.2. Cosmetic
    • 7.2.3. Orthopedic

Chapter 8. Global Hyaluronic Acid Raw Material Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Hyaluronic Acid Raw Material Market
    • 8.1.1. U.S. Hyaluronic Acid Raw Material Market
      • 8.1.1.1. Application breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Source breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Grade breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Hyaluronic Acid Raw Material Market
  • 8.2. Europe Hyaluronic Acid Raw Material Market
    • 8.2.1. U.K. Hyaluronic Acid Raw Material Market
    • 8.2.2. Germany Hyaluronic Acid Raw Material Market
    • 8.2.3. France Hyaluronic Acid Raw Material Market
    • 8.2.4. Spain Hyaluronic Acid Raw Material Market
    • 8.2.5. Italy Hyaluronic Acid Raw Material Market
    • 8.2.6. Rest of Europe Hyaluronic Acid Raw Material Market
  • 8.3. Asia-Pacific Hyaluronic Acid Raw Material Market
    • 8.3.1. China Hyaluronic Acid Raw Material Market
    • 8.3.2. India Hyaluronic Acid Raw Material Market
    • 8.3.3. Japan Hyaluronic Acid Raw Material Market
    • 8.3.4. Australia Hyaluronic Acid Raw Material Market
    • 8.3.5. South Korea Hyaluronic Acid Raw Material Market
    • 8.3.6. Rest of Asia Pacific Hyaluronic Acid Raw Material Market
  • 8.4. Latin America Hyaluronic Acid Raw Material Market
    • 8.4.1. Brazil Hyaluronic Acid Raw Material Market
    • 8.4.2. Mexico Hyaluronic Acid Raw Material Market
    • 8.4.3. Rest of Latin America Hyaluronic Acid Raw Material Market
  • 8.5. Middle East & Africa Hyaluronic Acid Raw Material Market
    • 8.5.1. Saudi Arabia Hyaluronic Acid Raw Material Market
    • 8.5.2. South Africa Hyaluronic Acid Raw Material Market
    • 8.5.3. Rest of Middle East & Africa Hyaluronic Acid Raw Material Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. AbbVie Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Salix Pharmaceuticals
    • 9.3.3. Lifecore Biomedical, Inc.
    • 9.3.4. Sanofi
    • 9.3.5. Anika Therapeutics, Inc.
    • 9.3.6. Zimmer Biomet
    • 9.3.7. Smith+Nephew
    • 9.3.8. LG Chem
    • 9.3.9. Maruha Nichiro Corporation
    • 9.3.10. Ferring B.V.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes